357 related articles for article (PubMed ID: 3084535)
1. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
Matsumoto AM; Karpas AE; Bremner WJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men.
Matsumoto AM; Paulsen CA; Bremner WJ
J Clin Endocrinol Metab; 1984 Nov; 59(5):882-7. PubMed ID: 6434586
[TBL] [Abstract][Full Text] [Related]
3. Follicle-stimulating hormone and human spermatogenesis.
Bremner WJ; Matsumoto AM; Sussman AM; Paulsen CA
J Clin Invest; 1981 Oct; 68(4):1044-52. PubMed ID: 6793629
[TBL] [Abstract][Full Text] [Related]
4. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of sperm production by human chorionic gonadotropin after prolonged gonadotropin suppression in normal men.
Matsumoto AM; Bremner WJ
J Androl; 1985; 6(3):137-43. PubMed ID: 3922931
[TBL] [Abstract][Full Text] [Related]
7. Follicle-stimulating hormone is required for quantitatively normal inhibin secretion in men.
McLachlan RI; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1305-8. PubMed ID: 3142919
[TBL] [Abstract][Full Text] [Related]
8. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
9. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
10. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
11. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
[TBL] [Abstract][Full Text] [Related]
12. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
13. The relative roles of follicle-stimulating hormone and luteinizing hormone in maintaining spermatogonial maturation and spermiation in normal men.
Matthiesson KL; McLachlan RI; O'Donnell L; Frydenberg M; Robertson DM; Stanton PG; Meachem SJ
J Clin Endocrinol Metab; 2006 Oct; 91(10):3962-9. PubMed ID: 16895950
[TBL] [Abstract][Full Text] [Related]
14. Endocrine control of human spermatogenesis.
Matsumoto AM; Bremner WJ
J Steroid Biochem; 1989 Oct; 33(4B):789-90. PubMed ID: 2513453
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
[TBL] [Abstract][Full Text] [Related]
16. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
[TBL] [Abstract][Full Text] [Related]
17. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
18. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
19. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]